Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

284 ARTÍCULOS , VIENDO DEL 181 AL 195

Belly Dancer Dyskinesia: A Case Report and Review of Management

Aboukar A, Ibrahim W.

Cureus. 2025 Sep 12;17(9):e92188. doi: 10.7759/cureus.92188. eCollection 2025 Sep.

Myoclonus as the first presenting manifestation of type 3c diabetes

Chatterjee S, Das S, Sengupta S, Ghosh R, Dubey S.

Neurol Sci. 2025 Dec 29;47(1):59. doi: 10.1007/s10072-025-08630-9.

Spontaneous Resolution of Pharyngeal Myoclonus in a Child: An Uncommon Case With Objective Clicking Sounds

Yokoyama K, Mamada M.

Cureus. 2025 Aug 6;17(8):e89518. doi: 10.7759/cureus.89518. eCollection 2025 Aug.

Stellate ganglion block for refractory periodic limb movement disorder: case report

Burshtein A, Aggarwal V, Kim JH.

J Neurol. 2025 Apr 11;272(5):335. doi: 10.1007/s00415-025-13054-8.

A Case Report of Abdominal Myoclonus Following Anterior Cerebral Artery Stroke

Nokhrina K, Wold J, Raghavan M, Lamotte G.

Tremor Other Hyperkinet Mov (N Y). 2025 Dec 17;15:64. doi: 10.5334/tohm.1119. eCollection 2025.

DHDDS-related disease; biallelic missense novel variant causing major severity with an early-onset epilepsy and hyperkinetic movement disorder

Gazeteci Tekin H, Edem P.

Int J Neurosci. 2025 Jun;135(6):726-730. doi: 10.1080/00207454.2024.2327405. Epub 2024 Mar 19.

[Neurodevelopmental and Movement Disorder Due to a Mutation in the GNAO1 Gene: A Case Report]

Hernández Yeneris SM, González-Solano MA, Lince-Rivera I, Rojas-Martínez JA, Ramón-Gómez JL.

Rev Neurol. 2025 Sep 22;80(8):46799. doi: 10.31083/RN46799.

Diagnostic Dilemma Between Autoimmune Encephalitis and SSPE: Case Report of Two Pediatric Patients

Jain S, James A, Varanasi SV, Botsa S, Choudhary A, Dahake U, Bang A, Girish M.

Indian J Pediatr. 2025 Jul;92(7):774-776. doi: 10.1007/s12098-025-05604-9. Epub 2025 May 30.

Refractory myoclonic epilepsy and progressive movement disorder arising from recurrent DHDDS variants in Japanese patients: a case series

Kobayashi Y, Sakuma S, Morimoto E, Fujii H, Yamada K, Hojo M, Miura M, Tohyama J, Miya F, Kato M, Saitsu H, Matsumoto N.

Brain Dev. 2025 Dec;47(6):104478. doi: 10.1016/j.braindev.2025.104478. Epub 2025 Oct 18.

Biomarkers of functional movement disorders - a systematic review

Dunalska A, Saramak K, Śmiłowska K, Carvalho V, Nicholls R, Abusrair A, Sławek J, Schmitt S, Klages C, Müller-Vahl KR, Szejko N.

Neurol Neurochir Pol. 2025;59(4):354-374. doi: 10.5603/pjnns.103052. Epub 2025 May 26.

Sleep Related Movement Disorders: What's New and Changing Clinical Practice

Stefani A, Tang Q, Clemens S, DelRosso LM, Garcia-Borreguero D, Ferri R, Frauscher B, Holzknecht E, Provini F, Schormair B, Winkelman J, Högl B.

J Sleep Res. 2025 Dec;34(6):e70210. doi: 10.1111/jsr.70210. Epub 2025 Oct 3.

Clinical neurophysiology for tremor: Common questions in clinical practice

Schwingenschuh P, Van der Stouwe M, Pandey S, Hirschbichler S, Panyakaew P, Kojovic M, Mukherjee A, Tijssen MA, Merchant SHI, Vial F; MDS Clinical neurophysiology Study group.

Parkinsonism Relat Disord. 2025 Jan;130:107196. doi: 10.1016/j.parkreldis.2024.107196. Epub 2024 Nov 23.

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Wong KM, Maroofian R, Meier K, Diegmann S, Tkemaladze T, Alvi JR, Tasharrofi B, Efthymiou S, Munchau A, Korenke GC, Almontashiri N, Eyaid W, Kashgari A, Alotaibi M, Gärtner J, Huppke B, Asadollahi M, Chikvinidze G, Keramatipour M, Sultan T, Thiele H, Nürnberg P, Gräler MH, Houlden H, Huppke P.

Mov Disord. 2025 Sep;40(9):1836-1850. doi: 10.1002/mds.30258. Epub 2025 Jul 1.

Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response

Zubarioglu T, Kadıoğlu-Yılmaz B, Köse E, Teke-Kısa P, Balcı MC, Yazıcı H, Özturk-Hişmi B, Akgün A, Kor D, Yıldız S, Kılıç-Yıldırım G, Soyuçen E, Akçalı A, Yıldız Y, Durmuş A, Güneş D, Soylu-Üstkoyuncu P, Kasapkara ÇS, Erdöl Ş, Göksoy E, Akar HT, Gümüş H, Ekmekçi AH, Eminoğlu FT, Arslan N, Hanağası HA, Canda E, Genç E, Özer I, Gündüz A, Kıykım E, Aktuğlu-Zeybek Ç.

J Inherit Metab Dis. 2025 Jul;48(4):e70069. doi: 10.1002/jimd.70069.

Polypharmacy-induced serotonin syndrome revealing underlying neurocognitive impairment and cervical myelopathy

Shah J, Parsons A, Pathuri S, Lieberman J, Hatten-Powell C.

BMJ Case Rep. 2025 Sep 25;18(9):e267753. doi: 10.1136/bcr-2025-267753.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias